Multiple system atrophy (MSA) is a progressive disorder with limited treatment options. However, recent research has yielded encouraging insights into new therapeutic approaches. Current efforts centers on modifying the underlying mechanisms of MSA. One strategy under investigation involves pharmacological interventions to influence the dysregulat